Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures (Tables)

v2.4.0.8
Segment Disclosures (Tables)
9 Months Ended
Sep. 30, 2014
Segment Disclosures [Abstract]  
Schedule of Segment Reporting Information

Segment reporting information is as follows:

 

  Engineering   Medical        
  Services   Devices     Total  

Three months ended September 30, 2014

                       
Revenue   $ 799,884     $ 788,299     $ 1,588,183  
Cost of revenue     529,657       578,737       1,108,394  
Gross profit (loss)   $ 270,227     $ 209,562     $ 479,789  
                         

Three months ended September 30, 2013

                       
Revenue   $ 417,082     $ 416,682     $ 833,764  
Cost of revenue     287,468       245,575       533,043  
Gross profit   $ 129,614     $ 171,107     $ 300,721  
                         

Nine months ended September 30, 2014

                       
Revenue   $ 1,841,355     $ 2,005,592     $ 3,846,947  
Cost of revenue     1,431,802       1,410,285       2,842,087  
Gross profit   $ 409,553     $ 595,307     $ 1,004,860  
                         

Nine months ended September 30, 2013

                       
Revenue   $ 1,375,010     $ 1,138,995     $ 2,514,005  
Cost of revenue     1,018,801       775,007       1,793,808  
Gross profit   $ 356,209     $ 363,988     $ 720,197  

 

Schedule of Geographic Information

Geographic information for revenue based on location of customer is as follows:

 

 

Three Months Ended

Nine Months Ended

 
 

September 30,

September 30,

 
  2014 2013     2014     2013  
                         
North America   $ 1,271,149     $ 700,316     $ 3,102,292     $ 2,195,004  
Europe, Middle East Asia     317,034       133,448       744,655       319,001  
    $ 1,588,183     $ 833,764     $ 3,846,947     $ 2,514,005